Tissue Banking Market Report and Forecast 2025-2034

The global tissue banking market was valued at USD 2.00 Billion in 2024, driven by the rapid advancements in technologies supporting ex vivo cord blood expansion across the globe. The market is anticipated to grow at a CAGR of 10.60% during the forecast period of 2025-2034 to achieve a value of USD 5.48 Billion by 2034.

Tissue Banking Market Overview

Tissue banking is the process of collecting, processing, storing, and distributing human tissues for clinical use, research, and education. These tissues, which may include skin, bone, corneas, heart valves, and tendons, are preserved through specialised techniques such as cryopreservation and sterilisation to maintain viability and safety. Tissue banks ensure the quality and traceability of samples, supporting various medical treatments including reconstructive surgeries, transplants, and regenerative therapies. By providing ethically sourced and regulated tissues, tissue banking plays a crucial role in advancing modern medicine and improving patient outcomes worldwide.

Tissue Banking Market Growth Drivers

Development of Private Biobanks to Advance Market Value

Rising emphasis on women-specific health research and increased funding for private tissue banks are key drivers of tissue banking market growth. For instance, in January  2025, BioGrad launched Europe’s first private women’s health research tissue bank, a 10,000 sq ft facility in Liverpool, following an EUR 25 million (USD 31.5 million) investment in women's health. The facility stores menstrual blood, peripheral blood, and umbilical cord tissues, targeting conditions like PCOS, endometriosis, and cancer. With partnerships including Liverpool Women’s Hospital and sample donor incentives, the initiative will significantly expand the scope and diversity of biobanking. Over the forecast period, this development is expected to improve sample availability, drive research innovation, and diversify tissue types in global repositories.

Rising Focus on Developing Targeted Therapies to Boost Tissue Banking Market Demand

Increasing demand for targeted therapies and investment in chronic disease research are key contributors to tissue banking market expansion. For instance, in October  2024, the Orland Bethel Family Foundation invested USD 18.5 million to develop a biological specimen repository at the Orland Bethel Family Musculoskeletal Research Center at the University of Pittsburgh. The repository aims to support research into arthritis and other musculoskeletal diseases, which affect millions globally. This initiative is expected to enhance specimen accessibility and long-term data generation for high-burden conditions. Over the forecast period, the project will likely accelerate musculoskeletal therapeutic discoveries and strengthen the research infrastructure, thus positively impacting the market.

Tissue Banking Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Regulatory Expansion Enhancing Tissue Banking for Allogeneic Therapies

In November 2024, BioRestorative Therapies, Inc. secured a provisional license from the New York State Department of Health to process allogeneic donor tissue for stem cell isolation and cryopreservation. Previously limited to autologous sources, this regulatory expansion now allows the company to bank and distribute clinical-grade off-the-shelf biologics. The development underscores the increasing role of regulatory advancements in enabling broader tissue banking capabilities. As demand rises for scalable, allogeneic stem cell therapies, particularly in regenerative medicine, such licensing frameworks are expected to significantly support market growth through improved standardisation, safety, and accessibility of stored human tissues globally.

Advancements in Cell-Based Therapies to Expand Tissue Banking Market Size

In July 2023, British Patient Capital invested EUR 10 million (12.6 million USD) in Tenpoint Therapeutics during a USD 70 million Series A round to accelerate regenerative ocular therapies. Tenpoint’s work in ex vivo and in vivo cell engineering aimed at restoring vision by replacing dysfunctional eye tissues highlights the rising demand for viable tissue sources, preservation techniques, and biobanking infrastructure. This shift towards innovative cell-based treatments is expanding the scope of tissue banking beyond transplantation into therapeutic and regenerative domains. The trend signifies an evolving landscape where tissue banks play a critical role in supporting next-generation treatments and clinical research globally.

Integration of AI and Biobanks to Advance Tissue Banking Market Growth

In November 2024, Barts Health secured a EUR 4.3 million (5.42 million USD) government grant as part of an EUR 18.9 million (USD 23.83 million) initiative aimed at integrating AI into cancer care. The project focuses on compiling cancer patient data and tissue bank samples into a secure platform to support advanced diagnostic and drug discovery tools. Spearheaded by Professors Louise Jones and Hemant Kocher from Barts Cancer Institute at QMUL, the initiative uses extensive biobank resources in breast and pancreatic cancer. This trend highlights how AI-driven research is elevating the role of tissue banks in precision medicine, driving innovation and growth in the market.

Growing Demand for Personalized Medicine Enhancing Tissue Banking Market Value

The increasing focus on personalized medicine is significantly shaping the future of tissue banking. As healthcare moves towards tailored therapies based on individual genetic and cellular profiles, the demand for high-quality, well-preserved human tissues has surged. These biospecimens are crucial for genomic studies, biomarker identification, and treatment planning. This growing integration of precision medicine with research and diagnostics is driving the need for advanced tissue banking infrastructure, encouraging innovation and investment. Consequently, this trend is expected to expand market value by ensuring tissue availability that supports bespoke treatment approaches in oncology and regenerative medicine.

Tissue Banking Market Segmentation

Tissue Banking Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Equipment
• Cryopreservation Equipment
• Thawing Equipment
• Quality Control Equipment
• Others
• Media and Consumables

Market Breakup by Tissue Type

• Heart Valves
• Cornea
• Bone
• Skin
• Brain and Spinal Cord
• Others

Market Breakup by Application

• Therapeutic
• Cosmetic
• Research and Development
• Drug Discovery
• Others

Market Breakup by End User

• Biobanks
• Hospitals and Clinics
• Research and Academic Institutes
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Tissue Banking Market Share

Media and Consumables to Dominate the Segmentation by Product

Media and consumables are anticipated to dominate the market by product due to their indispensable role in tissue preservation, processing, and storage. Unlike capital-intensive equipment, consumables such as storage vials, reagents, and cryoprotectants are required continuously across all procedures. Their recurrent usage in various workflows, including thawing, cryopreservation, and quality control, ensures a consistent revenue stream. As tissue banking expands into regenerative medicine, oncology, and personalised therapies, the demand for reliable consumables will further rise. Innovations in preservation solutions and increased biobanking activities globally are also set to bolster this segment’s growth during the forecast period.

Bone Tissues to Hold a Significant Tissue Banking Market Value for Segmentation by Tissue Type

Bone tissue is poised to lead the market by tissue type due to its wide-ranging applications in orthopaedic surgeries, trauma repair, and dental implants. The rising incidence of musculoskeletal disorders and sports injuries has driven demand for bone grafts and substitutes. Bone’s high transplantation success rate and ability to integrate with host tissues also contribute to its preference. Additionally, advancements in 3D printing and allograft processing technologies are supporting efficient bone tissue utilisation. These factors collectively position the bone segment as a dominant contributor to market value in the forecast years.

Therapeutic Applications to Lead the Segment by Application

Therapeutic applications are expected to capture the largest market share. The growing burden of chronic diseases, the increasing number of surgical procedures, and heightened demand for tissue transplants in areas such as cardiology, neurology, and orthopaedics are key drivers. Furthermore, the adoption of regenerative therapies, including stem cell-based treatments and skin grafts, underlines the therapeutic significance of stored tissues. Rising government and private investments in healthcare infrastructure are further promoting access to transplantation procedures. This segment's role in improving clinical outcomes makes it central to the market’s ongoing expansion.

Biobanks to Dominate the Tissue Banking Market Segmentation by End User

Biobanks are set to dominate the market by end user due to their specialised infrastructure and central role in large-scale tissue collection and preservation. These institutions are essential for supporting scientific research, drug development, and personalised medicine. Increasing collaborations between biobanks, academic institutions, and pharmaceutical companies are accelerating innovation and expanding sample diversity. Moreover, global health initiatives focusing on genomics and disease profiling are further boosting biobank activities. As regulatory frameworks evolve to support ethical biobanking, their capacity and operational scale are expected to grow, reinforcing their leadership in the market throughout the forecast period.

Tissue Banking Market Analysis by Region

North America is expected to hold the largest market share, driven by robust government support for biobanking, an advanced healthcare system, and an extensive network of research institutions. The U.S. boasts one of the highest numbers of registered tissue banks, alongside rising demand for regenerative and transplant-based therapies. Moreover, favourable regulatory frameworks and large-scale investments in personalised medicine are further expanding regional capabilities. Europe follows closely, supported by national biobank initiatives and strong academic collaborations. The Asia-Pacific region is gaining momentum, fuelled by rapid healthcare infrastructure development and growing stem cell research. Meanwhile, Latin America and the Middle East and Africa are witnessing gradual growth through public–private healthcare partnerships and medical tourism.

Leading Players in the Tissue Banking Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Rokit Healthcare Inc.

Headquartered in Seoul, South Korea, Rokit Healthcare Inc. was established in 2012 and is a leader in regenerative medicine and 3D bioprinting technologies. The company’s innovations include the Dr. INVIVO bioprinting platform, which supports personalised tissue engineering and biobank development. Rokit’s portfolio in the tissue banking market focuses on preserving and fabricating human tissues for wound care, skin regeneration, and medical research. Through advanced bioprinting and cell preservation solutions, the company is actively contributing to the advancement of personalised and regenerative therapies globally.

AMS Biotechnology (Europe) Limited

Founded in 1987 and headquartered in Abingdon, Oxfordshire, UK, AMS Biotechnology (AMSBIO) provides high-quality products and services for life sciences research. In the tissue banking sector, AMSBIO offers an extensive range of cryopreservation media, biorepository reagents, and human tissue samples for use in drug development and disease modelling. The company supports biobanks and research institutes with tools for tissue storage, stability, and viability. With a strong presence across Europe and North America, AMSBIO is advancing tissue research through reliable, scalable, and ethically sourced biobanking solutions.

Avantor, Inc. (VWR International)

Avantor, Inc., headquartered in Radnor, Pennsylvania, USA, traces its origins back to 1904, with VWR International being a significant subsidiary. The company supplies critical materials and consumables for biopharmaceutical and research applications. In tissue banking, Avantor offers cryogenic storage equipment, cryopreservation reagents, and laboratory-grade consumables used for safe tissue handling, transport, and preservation. Avantor’s global infrastructure supports tissue banks and clinical labs by ensuring quality-controlled environments and end-to-end biorepository support, playing a key role in accelerating therapeutic research and regenerative medicine initiatives.

Sartorius AG

Established in 1870 and headquartered in Göttingen, Germany, Sartorius AG is a global leader in laboratory and bioprocessing technologies. In the tissue banking domain, Sartorius provides state-of-the-art cell culture solutions, filtration systems, cryopreservation tools, and data monitoring software. Their products ensure optimal conditions for tissue storage and quality control. Sartorius supports tissue banks, research labs, and clinical manufacturers in maintaining regulatory compliance and ensuring tissue integrity. With a strong focus on digitalisation and innovation, Sartorius is enabling reliable tissue preservation for therapeutic, diagnostic, and research purposes.

Azenta Life Sciences

Azenta Life Sciences, headquartered in Burlington, Massachusetts, USA, emerged from the rebranding of Brooks Life Sciences in 2021. It specialises in sample management, genomic services, and automation solutions for biobanking and life sciences. Azenta provides secure, high-capacity storage solutions, temperature-controlled logistics, and comprehensive tissue sample tracking systems. With global biorepository facilities and cutting-edge cryogenic storage technologies, Azenta serves pharmaceutical companies, hospitals, and research institutions. Its focus on data integrity, regulatory compliance, and sustainability positions it as a vital partner in the global tissue banking ecosystem.

Other key players in the market include Bio-Rad Laboratories Inc., Eppendorf AG, Thermo Fisher Scientific Inc., LifeLink Tissue Bank, and BioLife Solutions.

Key Questions Answered in the Tissue Banking Market

• What was the global tissue banking market value in 2024?
• What is the global tissue banking market forecast outlook for 2025-2034?
• What is market segmentation based on product?
• What is market segmentation based on tissue type?
• What is market segmentation based on application?
• What is market segmentation based on end user?
• What are the major factors aiding the global tissue banking market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major global tissue banking market trends?
• Which product will lead the market segment?
• Which tissue type will lead the market segment?
• Which application will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the global tissue banking market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?